Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Vitrakvi approved in Japan for NTRK fusion-positive advanced or recurrent solid tumors

March 25, 2021

Kochi University discovers new KHSRP inhibitors

March 25, 2021

Chinese investigators patent TRK inhibitors

March 25, 2021

HiberCell identifies PERK inhibitors

March 25, 2021

Ferro Therapeutics synthesizes new PHGPx inhibitors

March 25, 2021

SF-1 antagonist OR-449 for treating ACC

March 25, 2021

Basilea reports further interim data from phase II study of derazantinib in bile duct cancer

March 24, 2021

Japanese approval of Lenvima for unresectable thymic carcinoma

March 24, 2021

Idorsia Pharmaceuticals synthesizes LGALS inhibitors

March 24, 2021

Bristol Myers Squibb divulges DGKA and/or DGKZ inhibitors

March 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...